Coger: Distributeur de reactifs de laboratoire
AVANTI POLAR LIPIDS , CYGNUS , LARODAN , ADIPOGEN , MYBIOSOURCE , SERVA NORDMARK, BIOWORLD, EDGEBIO , PANREAC APPLICHEM
|
Ajouter au panier
Le produit a été ajouté au panier Le stock est insuffisant. unités ont été rajoutées au panier Total:
|
|
Stock épuisé.
En rupture de stock
|
|
Quantité minimum d'achat
La quantité minimum d'achat n'est pas atteinte
|
PHA-690509
1 mg
photos non contractuelles
Détails Produit
Chemical. C17H21N3O2S. CAS: 492445-28-0. MW: 331.4. Cyclin-dependent kinases (CDKs) are key regulators of cell progression. CDK2 and CDK4 are responsible for phosphorylation of the Retinoblastoma (RB) protein causing activation of the E2F transcription factor and transcription of genes involved in the G1/S transition and initiation of DNA replication. Several CDK inhibitors are thus being developed as potential anti-cancer agents. PHA-690509 on such CDK inhibitor. PHA-690509 is a ATP-competitive CDK inhibitor with submicromolar IC(50) against multiple CDKs, in particular CDK2, its primary target (IC(50) 31nM). In cell proliferation assays, PHA-690509 demonstrated marked potency against several cells lines with IC(50) values in the submicromolar range primarily.
|
Alerte
Veuillez saisir les champs obligatoires! |
